Beximco Pharmaceuticals PLC. (DSE:BXPHARMA)
Bangladesh · Delayed Price · Currency is BDT 153.20
+5.20 (3.51%)
At close: Sep 3, 2026
DSE:BXPHARMA Balance Sheet
Financials in millions BDT. Fiscal year is July - June.
Millions BDT. Fiscal year is Jul - Jun.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Cash & Equivalents | 4,228 | 1,700 | 854.11 | 1,136 | 1,169 | 675.47 |
Short-Term Investments | 1,557 | 1,098 | 369.37 | 166.25 | 108.07 | 112.83 |
Cash & Short-Term Investments | 5,784 | 2,798 | 1,223 | 1,302 | 1,277 | 788.3 |
Cash Growth | 76.19% | 128.68% | -6.03% | 1.97% | 61.96% | 11.69% |
Accounts Receivable | 3,768 | 3,114 | 3,462 | 3,370 | 2,963 | 2,726 |
Other Receivables | - | 514.97 | 304.98 | 215.62 | 217.35 | 174.05 |
Receivables | 3,768 | 3,629 | 3,767 | 3,586 | 3,180 | 2,900 |
Inventory | 15,558 | 14,762 | 13,307 | 13,473 | 11,573 | 8,265 |
Prepaid Expenses | - | 178.83 | 136.62 | 60.96 | 53.23 | 36.03 |
Other Current Assets | 2,956 | 2,418 | 2,383 | 2,455 | 2,335 | 1,781 |
Total Current Assets | 28,067 | 23,786 | 20,818 | 20,876 | 18,419 | 13,771 |
Property, Plant & Equipment | 45,246 | 44,027 | 43,049 | 42,808 | 42,212 | 36,531 |
Long-Term Investments | 20.97 | 20.97 | 20.97 | 20.97 | 23.36 | 16.59 |
Goodwill | 674.57 | 674.57 | 674.57 | 674.57 | 674.57 | 546.69 |
Other Intangible Assets | 4,689 | 4,694 | 4,721 | 4,721 | 4,730 | 1,381 |
Long-Term Deferred Tax Assets | 33.78 | 44.08 | 60.89 | 56.51 | 88.64 | - |
Total Assets | 78,731 | 73,247 | 69,344 | 69,157 | 66,148 | 52,246 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Accounts Payable | 2,124 | 1,564 | 1,402 | 1,618 | 1,373 | 769.2 |
Accrued Expenses | 1,394 | 2,132 | 2,832 | 2,581 | 2,042 | 1,420 |
Short-Term Debt | 973.57 | 2,025 | 2,997 | 6,621 | 6,851 | 5,023 |
Current Portion of Long-Term Debt | 801.16 | 1,318 | 1,132 | 1,293 | 1,905 | 1,287 |
Current Portion of Leases | 90.39 | 118.38 | 139.3 | 146.52 | 160.58 | 113.98 |
Current Income Taxes Payable | 1,282 | 528.63 | 429.27 | 454.09 | 99.45 | 222.51 |
Current Unearned Revenue | - | 58.04 | 80.24 | 149.41 | 110.41 | 298.4 |
Other Current Liabilities | 137.93 | 648.55 | 551.38 | 401.5 | 193.85 | 214.81 |
Total Current Liabilities | 6,803 | 8,393 | 9,562 | 13,265 | 12,736 | 9,350 |
Long-Term Debt | 1,090 | 1,202 | 1,433 | 2,158 | 2,997 | 972.7 |
Long-Term Leases | 208.38 | 301.52 | 324.72 | 393.12 | 456.76 | 234.02 |
Pension & Post-Retirement Benefits | 3,952 | 2,175 | 2,104 | 1,876 | 1,624 | 1,322 |
Long-Term Deferred Tax Liabilities | 2,582 | 2,576 | 2,575 | 2,550 | 2,537 | 1,990 |
Other Long-Term Liabilities | - | 1,516 | 1,443 | 1,295 | 1,161 | 1,013 |
Total Liabilities | 14,635 | 16,163 | 17,441 | 21,537 | 21,512 | 14,881 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Common Stock | 4,461 | 4,461 | 4,461 | 4,461 | 4,461 | 4,461 |
Additional Paid-In Capital | 6,959 | 6,959 | 6,959 | 6,959 | 6,959 | 6,959 |
Retained Earnings | 47,184 | 40,240 | 35,079 | 30,806 | 27,748 | 24,180 |
Comprehensive Income & Other | 1,445 | 1,447 | 1,450 | 1,454 | 1,432 | 1,431 |
Total Common Equity | 60,048 | 53,107 | 47,950 | 43,681 | 40,600 | 37,031 |
Minority Interest | 4,048 | 3,977 | 3,953 | 3,939 | 4,036 | 334.31 |
Shareholders' Equity | 64,096 | 57,085 | 51,903 | 47,620 | 44,636 | 37,365 |
Total Liabilities & Equity | 78,731 | 73,247 | 69,344 | 69,157 | 66,148 | 52,246 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Total Debt | 3,163 | 4,966 | 6,025 | 10,612 | 12,371 | 7,631 |
Net Cash (Debt) | 2,621 | -2,168 | -4,802 | -9,310 | -11,094 | -6,843 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | 5.87 | -4.86 | -10.76 | -20.87 | -24.87 | -15.34 |
Filing Date Shares Outstanding | 446.11 | 446.11 | 446.11 | 446.11 | 446.11 | 446.11 |
Total Common Shares Outstanding | 446.11 | 446.11 | 446.11 | 446.11 | 446.11 | 446.11 |
Working Capital | 21,263 | 15,393 | 11,256 | 7,611 | 5,683 | 4,421 |
Book Value Per Share | 134.60 | 119.04 | 107.48 | 97.91 | 91.01 | 83.01 |
Tangible Book Value | 54,685 | 47,738 | 42,555 | 38,285 | 35,196 | 35,103 |
Tangible Book Value Per Share | 122.58 | 107.01 | 95.39 | 85.82 | 78.90 | 78.69 |
Land | 7,892 | 7,892 | 7,892 | 7,892 | - | 4,068 |
Buildings | 17,058 | 16,988 | 17,005 | 16,704 | - | 8,129 |
Machinery | 34,839 | 34,419 | 33,219 | 31,733 | - | 18,663 |
Construction In Progress | 5,307 | 3,293 | 1,938 | 1,847 | - | 16,507 |